2024
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention
Park D, Hu J, Jamil Y, Kelsey M, Jones W, Frampton J, Kochar A, Aronow W, Damluji A, Nanna M. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention. JAMA Network Open 2024, 7: e244000. PMID: 38546647, PMCID: PMC10979312, DOI: 10.1001/jamanetworkopen.2024.4000.Peer-Reviewed Original ResearchConceptsOlder adultsMonths of DAPTDuration of dual antiplatelet therapySystematic reviewRandomized clinical trialsPercutaneous coronary interventionMeta-analysisPreferred Reporting ItemsAssess data qualityRisk of bleedingDuration of DAPTDual antiplatelet therapyWeb of ScienceMain OutcomesReporting ItemsData extractionAbstracted dataSecondary outcomesRisk ratioAntiplatelet therapyPrimary outcomeCochrane LibraryCoronary interventionReference groupNetwork meta-analysis
2022
Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis
Park D, An S, Murthi M, Kattoor A, Kaur A, Ravi V, Huang H, Vij A. Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis. Journal Of Interventional Cardiac Electrophysiology 2022, 64: 763-771. PMID: 35258752, DOI: 10.1007/s10840-022-01168-2.Peer-Reviewed Original ResearchConceptsRecurrence of AFStudy of patientsHistory of AFAblation therapyAtrial fibrillationWeight lossRate of recurrence of AFSubgroup analysisRecurrence of atrial fibrillationRisk ratioEffects of weight lossSubgroup analysis of studiesLong-term recurrenceLost weightWeight loss groupMethodsAn extensive literature searchSystematic reviewStudies of weight lossConclusionWeight lossLow recurrenceMedical therapyLoss groupResultsEight studiesRecurrenceTherapy